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The accurate maintenance of genomic integrity is essential for tissue homeostasis. Deregulation of this process
leads to cancer and aging. BRCA1 is a critical mediator of this process. Here, we performed conditional deletion of
Brca1 during epidermal development and found that BRCA1 is specifically required for hair follicle (HF) formation
and for development of adult HF stem cells (SCs). Mice deficient for Brca1 in the epidermis are hairless and display
a reduced number of HFs that degenerate progressively. Surprisingly, the interfollicular epidermis and the
sebaceous glands remain unaffected by Brca1 deletion. Interestingly, HF matrix transient amplifying progenitors
present increased DNA damage, p53 stabilization, and caspase-dependent apoptosis compared with the inter-
follicular and sebaceous progenitors, leading to hyperproliferation, apoptosis, and subsequent depletion of the
prospective adult HF SCs. Concomitant deletion of p53 and Brca1 rescues the defect of HF morphogenesis and loss
of HF SCs. During adult homeostasis, BRCA1 is dispensable for quiescent bulge SCs, but upon their activation
during HF regeneration, Brca1 deletion causes apoptosis and depletion of Brca1-deficient bulge SCs. Our data
reveal a major difference in the requirement of BRCA1 between different types of epidermal SCs and progenitors
and during the different activation stages of adult HF SCs.
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The maintenance of genome integrity is crucial for tissue
development and homeostasis, and failure to preserve
genome maintenance may result in cancer, accelerated
aging, or both (Garinis et al. 2008; Hoeijmakers 2009). All
living cells are continuously challenged by DNA damage
caused by external stress and highly reactive by-products
of cellular metabolism or during DNA replication. Sev-
eral highly conserved DNA repair mechanisms exist in
eukaryotic cells to recognize and repair the multiple types
of DNA damage (Hoeijmakers 2001; Sancar et al. 2004;
Harper and Elledge 2007). The most deleterious type of
DNA lesions are double-strand breaks (DSBs), which are
repaired by homologous recombination (HR) during the S
and G2/M phases of the cell cycle and by nonhomologous
end-joining (NHEJ) during G0/G1. HR is an error-free DNA
repair mechanism, as it uses the intact sister strand as
a template to repair DNA DSBs, thereby accurately pre-
serving genetic information, while NHEJ ligates together
the broken ends and thus potentially results in small
deletions, nucleotide changes, or chromosomal transloca-
tions (Lombard et al. 2005). Mutations in either of these
pathways can result in premature aging, neurodegenera-
tion, and increased risk of cancer (Hakem 2008).
The skin epidermis is a stratified epithelium consisting
of the interfollicular epidermis (IFE) and its appendages:
the hair follicles (HFs) and the associated sebaceous
glands (SGs) (Blanpain and Fuchs 2006; Sotiropoulou
and Blanpain 2012). The homeostasis of these different
epidermal compartments is ensured by different pools of
resident stem cells (SCs), each of which is located in
a different niche (Blanpain and Fuchs 2009). Multipotent
HF SCs reside in the permanent region of the HF called
the bulge region and are responsible for the cyclic regener-
ation of the HF. The maintenance of the IFE is ensured by
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the presence of multiple units of proliferation containing
long-lived SCs and short-lived committed progenitors
(Clayton et al. 2007; Mascre et al. 2012). Finally, the
turnover of the SG and the maintenance of the infundib-
ulum, the part of the HF connected to the IFE, are
mediated by resident progenitors located in this region of
the HF and expressing different markers, such as MTS24,
Lrig1, and Lgr6 (Nijhof et al. 2006; Jensen et al. 2009;
Snippert et al. 2010). The epidermis is the outer barrier of
the body and thus is constantly exposed to mutagenic
assaults such as UV or ionizing radiation (Blanpain et al.
2011). Since epidermal SCs renew in the adult skin of
animals throughout their life, they are at high risk of ac-
cumulating DNA damage and mutations that can impair
their function. We showed recently that adult bulge SCs
are strongly resistant to DNA damage-induced cell death
through their higher expression of the anti-apoptotic pro-
tein Bcl2 and through accelerated DNA repair activity
mediated by NHEJ (Sotiropoulou et al. 2010). As the
different types of SCs in the epidermis exhibit distinct
turnover rates (Sotiropoulou and Blanpain 2012), the higher
activity of NHEJ found in adult bulge SCs may reflect their
relative quiescence (Blanpain et al. 2011), which poises
them to use NHEJ preferentially to repair their DNA. It is
not clear whether the different SCs located in the same
tissue rely on specific DNA repair mechanisms at a given
stage of development.
Recent studies have shown that adult SCs from distinct
tissues respond differently to DNA damage (Blanpain et al.
2011). Adult mouse hematopoietic SCs, similar to bulge
SCs, are more resistant to DNA damage-induced cell death
than their downstream progenitors (Mohrin et al. 2010),
while human neonatal cord blood SCs are more sensitive
to DNA damage (Milyavsky et al. 2010), suggesting that
either the species or the stage of SC ontogeny may dictate
the response to DNA damage. Since the different develop-
mental stages are characterized by distinct proliferation
rates, it is possible that HR and NHEJ are differentially
used during morphogenesis and homeostasis to preserve
the fitness and the pool of SCs at distinct stages of
development and activation.
Using conditional ablation of Brca1 during both em-
bryonic development and adult homeostasis, we assessed
the relative importance of BRCA1 in the specification and
maintenance of the different pools of SCs present in the
mouse epidermis. BRCA1 not only is a critical mediator of
HR (Huen et al. 2010), but also dictates the choice between
HR and NHEJ by displacing 53BP1 from the ends of the
DSBs (Bunting et al. 2010) or by blocking 53BP1 accumu-
lation (Chapman et al. 2012), enabling resection of the
break and initiation of HR. Interestingly, we found that the
distinct types of epidermal SCs respond differently to
Brca1 deletion. While the IFE and SG remain mostly
unaffected upon Brca1 deletion, BRCA1 is essential for
HF bulge SC development and homeostasis. Upon Brca1
deletion, transient amplifying matrix cells undergo p53-
dependent apoptosis, which induces continuous activa-
tion, extensive proliferation, and cell death of the pro-
spective bulge SCs, leading to their rapid exhaustion and
failure to sustain the homeostasis of the HF lineages.
Results
Brca1 deletion in the epidermis during embryonic
development results in a decreased number of HFs
BRCA1, a key mediator of DNA repair, is expressed in
every compartment of the skin epidermis, including the
IFE, SG, and HF (Supplemental Fig. 1). To define the im-
portance of BRCA1 during epidermal development, we
performed conditional deletion of Brca1 specifically in
the skin epidermis of K14Cre/Brca1fl/fl (Brca1 cKO [con-
ditional knockout]) mice, which express the Cre recom-
binase in the developing epidermis from embryonic day
12 (E12) and thereafter (Vasioukhin et al. 2001). At E17,
the epidermis is stratified, and P-cadherin-positive HF
rudiments are already visible at different stages of their
development (placodes, hair germs, hair pegs, and HFs)
(Rhee et al. 2006). Quantification of the number of em-
bryonic HFs at E17 demonstrated that Brca1 cKO mice
present a decrease of 50% in the number of HFs, which
are in a less advanced stage of maturation compared with
wild-type epidermis (Fig. 1A–C).
To determine whether the decrease in the number of
HFs in Brca1 cKO mice is due to a defect in the signaling
pathways instructing HF fate, we studied the activation
of the Wnt/b-catenin pathway, which is the first signal
required for HF morphogenesis (Blanpain and Fuchs
2006). As shown in Figure 1D, nuclear b-catenin was ob-
served in the developing placode and surrounding mes-
enchyme in the Brca1 cKO mice, demonstrating that the
loss of epidermal appendages is not due to a defect in the
Wnt/b-catenin signaling pathway. Similarly, Lhx2 (Fig.
1E), a transcription factor that controls HF development
and acts downstream from Wnt and Hedgehog signal-
ing during HF morphogenesis (Rhee et al. 2006), is also
normally expressed in the HFs of Brca1 cKO epidermis,
showing that Brca1 deletion does not alter the expression
of well-known HF determinants.
Another possibility is that the HF progenitors die by
apoptosis as a result of their inability to repair endoge-
nous DNA damage, leading to a decrease in the number of
HFs. To investigate this possibility, we assessed the
expression of active Caspase-3 in the epidermis at E17.
We found that the Brca1 cKO epidermis contains many
active caspase-3-positive cells, which were localized
mainly in the HF rudiments (Fig. 1F,G). To determine
whether apoptosis is the main cause of the decreased
number of HFs in Brca1 cKO mice, we administered the
pan-caspase inhibitor Z-VAD-FMK to pregnant mice from
E10 to E17. Interestingly, administration of Z-VAD-FMK
completely rescued the number of embryonic HFs in
the Brca1 cKO mice (Fig. 1H), demonstrating that the de-
creased number of HFs following Brca1 deletion in the
embryonic epidermis was indeed caused by apoptosis.
Deletion of Brca1 in the epidermis results
in degeneration of HFs, leading to a hairless phenotype
At birth, Brca1 cKO mice are healthy and do not differ
from their wild-type littermates. However, while hair
starts to be visible around postnatal day 6 (P6) in wild-
Sotiropoulou et al.
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type mice, Brca1 cKO mice remain hairless (Fig. 2A) and
never develop hair, showing that absence of hair in Brca1
cKO mice is not the result of a delay in HF development.
Since the cKO mice do initially develop about half the
HFs of wild-type mice during epidermal morphogenesis,
we performed a temporal analysis of the postnatal skin to
investigate the fate of the surviving HFs. As shown in
Figure 2B, BRCA1-deficient HFs were smaller, thinner,
and more twisted than their wild-type counterparts.
Moreover, after the first month of age, the lower part of
the HFs underneath the SG progressively degenerated and
was lost before the second postnatal month. Quantifi-
cation of HF density (Fig. 2C) revealed that the lower part
of the HFs (Fig. 2C, solid black line) was progressively lost
in Brca1 cKO epidermis, and at 2 mo of age, almost no
lower HFs could be seen in BRCA1-deficient mice, while
the upper part (Fig. 2C, dotted black line) was maintained.
To determine why BRCA1-deficient HFs never make
visible hair shafts, we analyzed the expression of HF
differentiation markers associated with the different
HF lineages. Surprisingly, despite the absence of macro-
scopic hair shafts, markers of the different HF lineages,
including the inner root sheath and the precortex
markers, were detected in BRCA1-deficient HFs (Fig.
2D) except for the very few cells expressing the medulla
markers AE15 and Desmocollin-2, demonstrating that
the absence of visible hair in BRCA1 deficiency did not
result from the inability of HF cells to undergo terminal
differentiation.
Brca1 deficiency does not impair renewal
and differentiation of the IFE and SG
To investigate whether the other epidermal lineages,
including the IFE and the SG, are also affected in Brca1
cKO mice, we investigated the expression of the differ-
entiation markers of the IFE. The expression of K1, K10,
and loricrin is unaffected in BRCA1-deficient epidermis.
Similarly, the expression of the isthmus progenitor marker
MTS24 and Lrig1, a marker of the junctional zone pro-
genitors, is largely unaffected in Brca1 cKO epidermis, and
functional SGs could be detected following Oil Red O
staining (Fig. 3). Altogether, these data indicate that the
functional defect of BRCA1 deficiency in the epidermis is
restricted to the lower part of the HFs.
Brca1 deficiency leads to a higher level of DNA
damage, p53 stabilization, and apoptosis in the lower
HF cells compared with the rest of the epidermis
To define why the lower HF is more sensitive to the loss
of BRCA1 than the rest of the epidermis, we analyzed
whether HFs present more DNA damage than the other
epidermal cells. To this end, we investigated the expres-
sion of the DNA damage markers gH2AX, which local-
izes at unrepaired DSBs (Bonner et al. 2008), and 53BP1,
which also clusters in foci at sites of DNA damage
(Schultz et al. 2000). Under physiological conditions,
nuclear gH2AX foci are very rare in wild-type epidermis,
although some cells of the HF matrix presenting one or
Figure 1. Brca1 deletion during embryonic
development results in a reduction of the
number of HFs. (A) Representative images
of the epidermis of E17 wild-type (WT) and
K14Cre;Brca1fl/fl (Brca1 cKO) mice. Arrows
indicate epidermal rudiments stained here
with P-Cadherin in red. (B) Quantification
of the number of embryonic HFs per milli-
meter of skin in wild-type and Brca1 cKO
mice, showing the decrease of the number
of rudiments in the cKO epidermis (n = 100
103 optical fields analyzed in five different
mice). (C) Quantification of the type of
epidermal rudiments in wild-type and Brca1
cKO animals. (D) b-Catenin expression in
wild-type and Brca1 cKO mice. (E) Lhx2
expression in E17 wild-type and Brca1 cKO
epidermis. Note the comparable expression
pattern of the two early HF markers in wild-
type and Brca1 cKO animals. (F) Apoptosis
in wild-type and Brca1 cKO mice as de-
termined by active caspase-3 immunofluo-
rescence. (G) Quantification of apoptotic
cells in immunofluorescence images of
wild-type and Brca1 cKO mice, showing
the high levels of apoptosis in the epidermis
of cKO mice (n = 50 103 optical fields
analyzed in five different mice). (H) Quantification of the embryonic HFs in wild-type and Brca1 cKO mice at E17 upon daily
injections to the pregnant female of the pan-caspase inhibitor Z-VAD-FMK or DMSO as a control from E10 to E17. Note the rescue of
the phenotype in the cKO mice exposed to the caspase inhibitor (n = 50 103 optical fields analyzed in seven different mice). Error bars
represent the SEM. Bars, 20 mm. (Plc) Placodes; (HG) hair germ; (HP) hair peg.
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a few gH2AX foci can be detected (apoptotic cells that
also express a high level of gH2AX, albeit not in foci,
have been excluded from the quantification) (Fig. 4A,B).
In contrast, several BRCA1-deficient lower HF cells
present gH2AX foci, and these cells usually contain
more gH2AX foci per cell (Fig. 4A–C). Likewise, 53BP1
clusters are more abundant in BRCA1-deficient lower HFs
compared with the other parts of the Brca1-null epidermis
and with wild-type lower HFs (Fig. 4D), supporting the
notion that the greater sensitivity of the lower part of the
HFs to Brca1 deletion is related to the increased accumu-
lation of DNA damage in these cells.
DNA damage triggers p53 stabilization, which in turn
mediates a transient cell cycle arrest to allow the cells to
repair DNA damage, and if the damage is too extensive or
cannot be repaired, this triggers apoptosis (Riley et al.
2008). To determine whether Brca1 deletion in the epider-
mis induces p53 stabilization, we performed immuno-
staining for p53 and active Caspase-3 in skin sections of
wild-type and Brca1 cKO mice (Fig. 4E,G) and quantified
the number of positive cells in the different epidermal
compartments (Fig. 4F,H). As for gH2AX and 53BP1 foci,
the number of p53 and active Caspase-3-positive cells is
increased in the epidermis of Brca1 cKO mice, especially
in the lower part of the BRCA1-deficient HFs (Fig. 4F,H).
These results suggest that a higher number of unrepaired
DSBs specifically at the lower part of the Brca1 cKO HFs
leads to increased p53 stabilization and apoptosis.
Given the progressive degeneration of the lower HFs,
we investigated the number, proliferation, and apoptosis
of matrix progenitors. While the number of matrix cells in
wild-type mice remains constant from P10 to P14, the
Figure 2. Brca1 deletion in the epidermis leads to congenital alopecia and progressive degeneration of the HFs. (A) Macroscopic
pictures of wild-type (WT) and Brca1 cKO mice at P10 (d10) illustrating the complete absence of hair in Brca1 cKO mice. (B) Kinetics of
the HF cycle in wild-type and cKO epidermis. Note the progressive degradation of the lower part of the HFs under the SG. (C)
Quantification of the number of HFs per millimeter of skin. For the cKO mice, the solid line represents the number of complete HFs,
while the dotted line indicates the number of HFs irrespective of the presence of a lower part (n = 50 103 optical fields analyzed in five
different mice). (D) Immunofluorescence analysis of the HF differentiation markers illustrating the presence of cells expressing HF
differentiation markers in the Brca1 cKO mice, except from the medulla markers AE15 and Dsc2. Error bars represent the SEM. Bars, 20
mm. (Dsc2) Desmocollin 2.
Figure 3. The IFE and SGs are unaffected upon Brca1
deletion. Immunofluorescence analysis of markers of
the IFE and SG showing the normal expression of IFE
and SG differentiation markers as well as their pro-
genitor cells in Brca1 cKO mice. Note the comparable
expression of all of the factors in wild-type (WT) and
cKO mice. Bars, 20 mm.
Sotiropoulou et al.
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number of matrix cells decreases in Brca1 cKO animals
(Fig. 4I). To define the reason for this decrease in matrix
size, we analyzed proliferation and cell death in these
transient amplifying cells in wild-type and Brca1 cKO
mice. BrdU incorporation was decreased by 30% (Fig.
4J,K), and a high number of active Caspase-3-positive
cells (Fig. 4L,M) was observed in the BRCA1-deficient
matrix cells. These data clearly show that the progressive
reduction in the pool of HF transient amplifying cells in
BRCA1-deficient epidermis is the consequence of their
increased cell death, which cannot be compensated for by
increased proliferation of surviving cells.
Absence of slow-cycling adult HF bulge SCs
in BRCA1-deficient epidermis
The lower part of the HF is maintained by slow-cycling
multipotent SCs located in the permanent portion of the
HF called the bulge, located underneath the SG. Bulge
SCs are responsible for the regeneration of the new
HFs at each hair cycle and express high levels of CD34
(Trempus et al. 2003; Blanpain et al. 2004; Tumbar et al.
2004). Immunostaining and FACS analysis show the
complete absence of bulge SCs expressing CD34 in the
adult Brca1 cKO mice (Fig. 5A,B). Since CD34, the only
Figure 4. The HF matrix exhibits a higher
level of DNA damage, p53 expression, and
apoptosis upon Brca1 deletion. (A) Repre-
sentative confocal microscope images of
gH2AX foci in the IFE (top panels) or the
matrix (bottom panels) of P10 wild-type
(WT) and Brca1 cKO mice. The dotted lines
indicate the border of the epidermis with
dermis, while the solid lines delineate the
individual cells. (B) Quantification of gH2AX
foci in immunofluorescent images as pre-
sented in A. Four-hundred-fifty IFE cells,
550 upper HF cells, and 1500 lower HF
cells belonging to 10 different HFs from
each one of three independent mice were
counted. (C) Western blot analysis of gH2AX
expression in FACS-isolated IFE and lower
HF cells from wild-type and Brca1 cKO
mice. B-Actin was used as loading control.
(D) Representative images of 53BP1 expres-
sion in the IFE (left panels) and matrix (right
panels) of wild-type and Brca1 cKO mice.
Note the abundance of 53BP1 foci in the
lower HFs of the cKO mice. (E,F) Immuno-
histochemistry images and quantification
of the p53+ cells in the distinct compart-
ments of the epidermis. While present
throughout the tissue, note the higher
number of cells and the stronger expression
of p53 in the lower part of the HFs. (G,H)
Immunofluorescent images and quantifica-
tion of the apoptotic cells in the distinct
compartments of the epidermis using ac-
tive caspase-3 staining. (I) Quantification
of the number of HF matrix cells in longitu-
dinal sections in wild-type and Brca1 cKO
mice at the indicated time points, illustrat-
ing the rapid decrease in the matrix size in
the Brca1 cKO animals (n = 20 HFs encom-
passing between 600 and 1750 cells from
three different mice). (J,K) Representative
images and quantification of proliferating
cells in the matrix of P10 wild-type and
Brca1 cKO mice using BrdU labeling after
24-h BrdU pulse. Note the lower prolifera-
tion rate of the matrix in the Brca1 cKO
mice (n = 20 HFs encompassing between 700 and 1200 cells from each of three individual mice). (L,M) Representative images and
quantification of apoptotic cells in the matrix in P10 wild-type and Brca1 cKO mice using active caspase-3 immunofluorescence
and AE13 to delineate the limits of the matrix (n = 20 HFs encompassing between 600 and 1750 cells from three different mice).
Error bars represent the SEM. Bars, 20 mm. (Mx) matrix.
Hair follicle degeneration upon Brca1 deletion
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specific marker for bulge SCs, begins to be expressed
around P21 (Blanpain et al. 2004), we could not deter-
mine whether bulge SCs were never specified in the
Brca1 cKO mice or were initially normally specified but
subsequently lost.
It has been shown recently that the slow-cycling prop-
erty of prospective bulge SCs occurs early during HF
morphogenesis (Nowak et al. 2008). To determine whether
the prospective bulge SCs were specified and then lost
during HF morphogenesis, we assessed whether slow-
cycling cells could be detected in BRCA1-deficient epider-
mis using label retention studies. To this end, mice were
pulsed with BrdU from P3 to P5 and chased for 2 wk. As
shown in Figure 5, C and D, label-retaining cells (LRCs)
are concentrated in the bulge area of the wild-type mice,
while very few BrdU LRCs are detected in the Brca1 cKO
epidermis. However, because BrdU causes a certain level
of DNA damage and Brca1 cKO mice exhibit defects in
DNA repair, we cannot exclude the possibility that BrdU
administration may induce apoptosis in the prospective
bulge SCs. To circumvent the problem of the potential
BrdU toxicity, we used K5-tTA/TetO-H2B-GFP mice to
perform label retention studies with H2B-GFP, which
has been successfully used to mark slow-cycling bulge
SCs in adult mice (Tumbar et al. 2004) as well as during
HF morphogenesis (Nowak et al. 2008). Doxycycline
was continuously administered to K5-tTA;TetO-H2B-
GFP;K14Cre;Brca1fl/fl mice to induce the chase of H2B-
GFP starting at E18.5, and the mice were analyzed at P22.
As previously reported (Nowak et al. 2008), most H2B-
GFP-high LRCs are located in the bulge area of wild-type
mice, consistent with the acquisition of the slow-cycling
properties of the prospective bulge SCs during HF mor-
phogenesis (Fig. 5E). In sharp contrast, there were almost
no H2B-GFP-high LRCs in Brca1 cKO epidermis (Fig. 5E).
Quantification of the level of H2B-GFP fluorescence by
flow cytometry showed that <1% of cells in the Brca1 cKO
epidermis underwent fewer than four divisions, contrast-
ing with the 6% of H2B-GFP LRCs observed in wild-type
mice (Fig. 5F). Moreover, NFATc1, another marker of the
prospective quiescent bulge SCs (Horsley et al. 2008),
was initially detected in Brca1 cKO mice (data not
shown) but was lost over time (Fig. 5G), further suggest-
ing that prospective bulge SCs progressively lost their
quiescence feature.
To determine the cellular mechanisms leading to the
absence of adult CD34 bulge SCs in Brca1-deficient epi-
dermis, we excluded ectopic differentiation (Supplemen-
tal Fig. 2A) and performed a detailed temporal analysis of
proliferation and apoptosis in the prospective bulge re-
gion of Brca1 cKO mice during HF morphogenesis (Fig.
5H–J; Supplemental Fig. 2B). To delineate the prospective
bulge area, we used nephronectin (NPNT), an extracellu-
lar matrix protein expressed in the restricted region of
the upper part of the lower outer root sheath cells that
includes the prospective bulge SCs from early postnatal
days (Supplemental Fig. 2C; Fujiwara et al. 2011). As
shown in Figure 5H, the prospective bulge SCs in Brca1
cKO mice exhibited a fivefold to 10-fold higher rate of
BrdU incorporation compared with their wild-type lit-
Figure 5. Absence of quiescent adult HF SCs in BRCA1-de-
ficient epidermis. (A,B) Representative images and quantification
by FACS of adult bulge SCs labeled with CD34 in P47 wild-type
(WT) and Brca1 cKO mice, demonstrating the complete absence
of bulge SCs in the Brca1 cKO animals. (C,D) Representative
images and quantification by FACS of the LRCs after BrdU
pulse from P3 to P5 and 15 d of chase, demonstrating the reduction
of LRCs in Brca1 cKO epidermis (n = 4 mice for each condition).
(E) Representative images of H2B-GFP expression in P22 (d22)
Brca1fl/fl;K5tTA;H2B-GFP (wild-type) and K14Cre;Brca1fl/fl;
K5tTA;H2B-GFP (Brca1 cKO) mice treated continuously with
doxycycline from E18.5, confirming the lack of H2B-GFP LRCs
in the prospective bulge area of the Brca1 cKO epidermis. (F)
Quantification by FACS of the number of H2B-GFP+ cells in wild-
type and cKO mice as described in E. A FACS gate was set for
living basal cells that present a level of fluorescence indicating
that they accomplished less than four divisions. (G) Immunoflu-
orescence analysis of Nfatc1, a marker of quiescence, showing
the significant reduction of Nfatc1 expression in the prospective
bulge area of Brca1 cKO mice. (H) Quantification of proliferating
cells in the prospective bulge region, delineated with NPNT
immunostaining, of wild-type and Brca1 cKO mice at the in-
dicated ages using BrdU labeling after 24-h BrdU pulse (n = 1000
cells from each of two individual mice). (I) Representative images
of active caspase-3 and NPNT immunostaining on serial sections
of a P12 (d12) Brca1 cKO mouse. The lines indicate the bulge
areas as determined by NPNT expression, and the arrow is
pointing to an apoptotic bulge SC. (J) Quantification of apoptotic
prospective bulge SCs, as presented in I, at the indicated ages.
Note the peak of apoptosis at P12 (d12) (n = 10,000 cells from
each of two individual mice per time point). Error bars represent
the SEM. Bars, 20 mm. (Bu) Bulge.
Sotiropoulou et al.
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termates, with a peak of proliferation at P10 (10% of
BrdU-positive cells). At this time point, only very few
prospective bulge SCs (<0.2%) were caspase-3-positive
(Fig. 5J), suggesting that at P10, bulge SCs actively
proliferate to compensate for the high amount of cell
death in HF matrix TA cells (10–20 times more active
caspase-3-positive cells compared with the prospective
bulge SCs). Proliferation remained higher in Brca1-
deficient prospective bulge cells throughout HF mor-
phogenesis, while apoptosis peaked at P12 (0.5% of active
caspase-3-positive cells), 2 d after the peak of prolifera-
tion, and decreased to 0.2% thereafter (Fig. 5J).
Collectively, these data indicate that Brca1-deficient
prospective bulge SCs initially proliferate to compensate
for the massive apoptosis of HF TA matrix cells, and this
hyperproliferation is accompanied by a slight but signi-
ficant increase in their apoptosis that contributes to
the premature exhaustion of these progenitor cells, lead-
ing to the absence of adult bulge SCs in Brca1-deficient
epidermis.
Deletion of p53 rescues the hairless phenotype and the
lack of bulge SCs in the BRCA1-deficient epidermis
Our data indicate that unrepaired DNA damage, p53
stabilization, and apoptosis of HF transient amplifying
matrix cells could be responsible for the hairless pheno-
type and the absence of bulge SCs in adult mice. To test
this possibility functionally, we performed conditional
deletion of p53 together with Brca1 deletion. Interest-
ingly, concomitant deletion of p53 completely rescues
HF development and the specification of adult bulge SCs
in BRCA1-deficient epidermis (Fig. 6A–C), demonstrat-
ing that p53-dependent cell death of the lower HF is the
main mechanism leading to the absence of HF differen-
tiation and the lack of HF bulge SCs in Brca1-deficient
epidermis.
Deletion of Brca1 during adult homeostasis results
in the progressive depletion of Brca1-deficient bulge
SCs during HF regeneration
To define whether BRCA1 is also essential for the main-
tenance of adult HF bulge SCs, we performed conditional
deletion of Brca1 in the adult epidermis, when the pool of
bulge SCs is already established. To this end, we admin-
istered 15 mg of tamoxifen (TAM) over 2 wk to 4-wk-old
K5CreER;Brca1fl/fl;Rosa-YFP mice to delete Brca1 specif-
ically in the adult epidermis (adult Brca1 cKO) (Fig. 7A).
After TAM administration, only very rare BRCA1+
cells could be detected by immunohistochemistry in
K5CreER;Brca1fl/fl;Rosa-YFP-treated mice (Fig. 7B). Quan-
tification of the number of cells expressing YFP revealed
that 75% of the bulge SCs and 50% of the other epidermal
cells had undergone recombination at the Rosa26 locus
(Supplemental Fig. 3A,B). To determine more precisely
the frequency of TAM-induced Brca1 recombination, we
quantified by real-time PCR the relative frequency of
Figure 6. p53 deletion rescues HF differen-
tiation and the loss of adult HF SCs. (A)
Image of P47 (d47) Brca1fl/fl;p53fl/fl (wild-
type [WT]) and K14Cre;Brca1fl/fl;p53fl/fl
(Brca1/p53 cKO) mice, demonstrating the
rescue of the hair phenotype in Brca1 cKO
mice by concomitant inactivation of p53.
(B,C) Representative images and quantifica-
tion by FACS of the adult HF bulge SC in
P47 (d47) wild-type and Brca1;p53 double
cKO mice, showing that p53 rescues the SC
phenotype of BRCA1-deficient mice. (D)
Model of functional consequences of Brca1
deletion in the skin epidermis. Brca1 de-
letion in skin epidermis leads to increased
DNA damage, p53 stabilization, and cas-
pase-dependent apoptosis in the HF tran-
sient amplifying matrix cells, inducing
compensatory proliferation of the bulge HF
SCs to replenish the dying matrix progeni-
tors. This hyperproliferation is accompa-
nied by a defect in the balance between
self-renewal and differentiation of HF bulge
SC progenitors and concomitant apoptosis,
leading to their exhaustion and the degen-
eration of the lower (n = 4 animals for each
condition). Error bars represent the SEM.
Bars, 20 mm.
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recombined and nonrecombined Brca1 floxed alleles in
FACS-sorted epidermal populations. Following TAM
administration, the frequency of the nonrecombined al-
lele strongly decreased, while the frequency of the re-
combined Brca1 allele almost reached the level found
upon constitutive epidermal Brca1 deletion (K14Cre;
Brca1fl/fl mice) (Fig. 7C; Supplemental Fig. 3C). Surpris-
ingly, K5CreER;Brca1fl/fl;Rosa-YFP TAM-induced mice
regrew hair after shaving, albeit with some delay com-
pared with the control mice treated with TAM (Fig.
7D,E). To determine the effect of Brca1 deletion in adult
bulge SCs, we analyzed the expression of CD34 by immu-
nostaining and FACS. The similar frequency of CD34-
expressing cells in wild-type and K5CreER;Brca1fl/fl;Rosa-
YFP mice at different time points following TAM admin-
istration, in which most adult bulge SCs were initially
deficient for BRCA1 (Fig. 7F,G), suggests that either
BRCA1 is not essential for adult bulge SC maintenance
or Brca1-deficient bulge SCs were outcompeted by the few
remaining nonrecombined Brca1 wild-type bulge SCs
during the next stage of HF regeneration. Indeed, while
after TAM administration to K5CreER;Brca1fl/fl;Rosa-YFP
mice, bulge SCs were mostly BRCA1-negative, in the
newly formed HFs, they were always BRCA1-positive,
and 10 wk post-TAM, most of the bulge SCs expressed
BRCA1 (Fig. 7H). Moreover, a time-course analysis of the
expression of the Brca1 recombined allele by quantita-
tive PCR showed that the frequency of the recombined
allele progressively decreased over time during HF re-
generation, and the newly formed HFs contained a very
low level of the Brca1 recombined allele (Fig. 7I), demon-
strating the requirement of BRCA1 for adult HF regener-
ation and the progressive loss of adult Brca1-deficient
bulge SCs over time. Analysis of apoptosis of bulge SCs
following Brca1 deletion revealed that at the end of TAM
administration, when most Brca1-deficient bulge SCs
were in their resting stage, no increase in apoptosis was
detected in CD34 bulge cells (Fig. 7J). However, when
Figure 7. Brca1 deletion in adult HF bulge SCs
leads to their progressive depletion. (A) Scheme
presenting the strategy used to induce Brca1
deletion in adult epidermis and to monitor its
functional consequences. (B) Immunohistochem-
istry of BRCA1 after TAM administration to
wild-type (WT) and K5CreER;Brca1fl/fl;Rosa-
YFP (adult Brca1 cKO) mice. (C) Quantitative
PCR analysis of the expression of the recom-
bined Brca1 allele after TAM administration
performed on FACS-isolated keratinocytes. Re-
sults are presented relative to b-actin expression
(n = 5 animals for each condition). (D) Represen-
tative pictures of wild-type and adult Brca1 cKO
mice just after, 4 wk after, and 10 wk after TAM
administration. (E) Histogram showing the time
required before observing hair regrowth in wild-
type and adult Brca1 cKO mice after TAM ad-
ministration (n = 12 mice for each condition).
(F,G) Representative immunofluorescence and
FACS quantification of CD34 expression in
wild-type and adult Brca1 cKO mice immedi-
ately and 1 wk after TAM administration and
upon hair regrowth (n = 5 mice for each condi-
tion). (H) BRCA1 immunohistochemistry in the
bulge and the newly formed HFs after TAM
administration and upon hair growth. Note the
BRCA1 expression in the newly formed HFs and
in the bulge after hair growth in adult Brca1 cKO
TAM-treated mice. (I) Quantitative PCR analy-
sis of the expression of the recombined Brca1
allele on FACS-sorted CD34+ and YFP+ outer
root sheath cells at the indicated time points
after TAM administration. Results are presented
relative to b-actin expression. Note the reduction
in the expression of the recombined Brca1 allele
in the bulge SCs of adult Brca1 cKO TAM-treated
mice (n = 5 animals for each condition). (J)
Quantification of apoptosis in the bulge SCs as
determined by active caspase-3 immunostaining
in wild-type and adult Brca1 cKO mice at the
indicated time points. Note the increase of bulge CD34 SC apoptosis during anagen (n = 6000 cells for each of two mice per
condition). Error bars represent the SEM. Bars, 20 mm. (Bu) Bulge; (ORS) outer root sheath.
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HFs entered anagen and bulge SCs were activated, in-
creased frequency of active caspase-3 was observed in
CD34-expressing cells from K5CreER;Brca1fl/fl;Rosa-YFP-
treated mice (Fig. 7J). Collectively, these data show that
BRCA1 is dispensable for adult bulge SC maintenance
during the quiescent stage, but BRCA1 is required during
the active stage that accompanies HF regeneration.
Discussion
Our study shows that BRCA1 deficiency in the epidermis
impairs HF morphogenesis and the development and
homeostasis of adult HF bulge SCs, while the upper part
of the epidermis—the IFE and SG—remains unaffected. A
combination of direct and indirect consequences of Brca1
deletion cooperate to trigger the loss of HF SCs. The
increased p53-mediated apoptosis of HF matrix TA cells
induces intense proliferation of prospective bulge SCs to
compensate for the loss of HF progenitors. This hyper-
proliferation must be accompanied by a defect in the bal-
ance between self-renewal and differentiation, shifting
the equilibrium toward enhanced HF differentiation in
order to replenish the rapidly dying HF TA matrix cells. In
addition, the low but persistent apoptosis in the rapidly
proliferating prospective bulge cells further contributes
to their exhaustion and depletion and to the subsequent
degeneration of the lower part of the HFs (Fig. 6D). Like-
wise, during skin homeostasis, BRCA1 is not essential for
adult HF bulge SCs during their quiescent stage, possibly
because quiescent bulge SCs preferentially use NHEJ to
maintain their genomic integrity (Sotiropoulou et al.
2010; Symington and Gautier 2011). However, upon ac-
tivation of bulge SCs during HF regeneration, Brca1 dele-
tion leads to apoptosis and elimination of Brca1-deficient
bulge SCs.
The progressive degeneration of HFs upon Brca1 de-
letion results from p53-dependent apoptosis of matrix
cells. Simultaneous deletion of p53 completely rescued
HF morphogenesis and differentiation as well as the loss
of adult bulge SCs in BRCA1-deficient epidermis. It has
been shown that Brca1 deletion in a p53-null background
alleviates the phenotype of BRCA1 deficiency, rescuing
mice from embryonic lethality but resulting in premature
aging and tumorigenesis (Cao et al. 2003). BRCA1 is a
multifunctional protein (Huen et al. 2010), and the effects
of the p53 deletion in BRCA1-deficient cells may vary be-
tween different tissues. It is therefore possible that p53
deletion may only partly or transiently rescue the observed
HF SC phenotype. The demonstration that HF morpho-
genesis and differentiation are at least initially fully
rescued in Brca1/p53 double cKO mice demonstrates
the essential role of p53-mediated cell death in this
phenotype. The preferential apoptosis of matrix cells
committed to the inner cells of the future hair shaft
results in the absence of the tight and aligned packing
of premedulla cells, required to form the rigid multilayer
sheath of the hair shaft (Birbeck and Mercer 1957; O’Guin
et al. 1992).
While conditional deletion of Brca1 using K14Cre
has been previously performed, it did not result in the
absence of HF morphogenesis or differentiation (Liu et al.
2007; Rottenberg et al. 2007). However, the K14Cre line
used in these experiments displays mosaic expression
in the skin (Jonkers et al. 2001), thereby enabling HF
morphogenesis by cells that escaped Brca1 deletion.
Outcompetition of recombined cells by nonrecom-
bined wild-type cells usually occurs when deletion of
genes essential for SC renewal is induced in a mosaic
manner. In contrast, the K14Cre used in our study is
not mosaically expressed and results in Cre-mediated
recombination in all epidermal cells starting at E12
(Vasioukhin et al. 1999), preventing the emergence of
nonrecombined Brca1-positive cells that could contribute
to hair morphogenesis.
The most important question arising from our study is
why the upper part of the epidermis—the IFE and SG—is
unaffected by Brca1 deletion, while the HFs degenerate.
In the wild-type mice, BRCA1 is equally expressed in all
epidermal compartments, showing that the differential
response to Brca1 deletion cannot be explained by the
absence of BRCA1 expression from the upper part of the
epidermis. The exquisite sensitivity of HF matrix cells
upon Brca1 deletion is reminiscent of its role in the early
cortical progenitors during brain development (Pulvers
and Huttner 2009). Which mechanism could underpin
the differential requirement of BRCA1 in different types
of SCs? Are HF matrix progenitors more sensitive or are
IFE and SG SCs more resistant to Brca1 deletion? It is
possible that higher metabolic activity or lower reac-
tive oxygen species (ROS) buffering might lead to more
extensive endogenous DNA damage and subsequently
increase the need for DNA repair. Alternatively, other
DNA repair mechanisms might compensate for the loss of
BRCA1 in IFE and SG SCs. It has been demonstrated
recently that loss of 53BP1 rescues BRCA1 deficiency by
re-enabling HR (Bouwman et al. 2010; Bunting et al.
2010). However, the similar levels of 53BP1 expression
in the IFE and SG suggest that differential expression of
53BP1 in distinct epidermal SCs is not the primary
mechanism underlying the differential sensitivity of
these different SC populations to Brca1 deletion. Future
studies will be required to determine whether other
components of HR and NHEJ that are able to restore HR
in the absence of BRCA1, such as RAD51 (Martin et al.
2007), are differentially expressed in the distinct epider-
mal compartments, thereby contributing to the specific
requirement of BRCA1 in the HF lineages.
BRCA1 is a multifunctional protein involved in differ-
ent aspects of the DNA damage response, such as DNA
repair, checkpoint control, DSB resection, ubiquitination,
and chromatin remodeling (Starita and Parvin 2003; Huen
et al. 2010; Roy et al. 2012). Interestingly, BRCA1, when
partnered with BARD1, controls centrosome numbers
through monoubiquitination of g-tubulin (Xu et al. 1999;
Starita et al. 2004) and mitotic spindle assembly (Joukov
et al. 2006). It is thus possible that other BRCA1 functions
besides HR might be required in HF matrix cells to sustain
their proliferation and prevent their apoptosis. Finally,
BRCA1 may contribute to the maintenance of the hetero-
chromatin and subsequent gene silencing (Zhu et al. 2011).
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Analysis of the heterochromatin and the normally re-
pressed genes might reveal whether this function of
BRCA1 plays any critical role in the renewal or differen-
tiation of the HF lineages. Further studies, including
genomic and proteomic analyses, will be helpful to dis-
criminate between these different possibilities.
BRCA1 is one of the two main genes associated with
familial breast cancer. Germline mutations in BRCA1
lead to a major increase in the incidence of breast and
ovarian cancers, while other epithelia expressing BRCA1
do not show increased tumor formation (Venkitaraman
2009). Our study, demonstrating that certain SCs are lost
upon homozygous Brca1 deletion and consequentially
cannot induce cancer formation unless p53 is concomi-
tantly deleted, provides a possible explanation for this
important question. Moreover, understanding the molec-
ular basis of the differential sensitivity of distinct types of
SCs to Brca1 deletion will also be important to define the
molecular mechanisms of tissue degeneration and will




Brca1fl/fl (Liu et al. 2007) and p53fl/fl (Jonkers et al. 2001) mice
were obtained from the National Cancer Institute at Frederick.
Rosa-YFP mice (Srinivas et al. 2001) were obtained from Jackson
Laboratory. K14Cre (Vasioukhin et al. 1999) and TRE-mCMV-
H2B-GFP (Tumbar et al. 2004) mice were a kind gift from
E. Fuchs (Howard Hughes Medical Institute, The Rockefeller
University, New York). K5tTA mice (Diamond et al. 2000) were
a kind gift from A. Glick (Laboratory of Cellular Carcinogenesis
and Tumor Promotion, National Cancer Institute, Bethesda,
MD). The K5CreER mice were a kind gift from B. Hogan
(Department of Cell Biology, Duke University Medical Center,
Durham, NC). All animal experiments were performed in
accordance with the guidelines of the Free University of Brussels
(ULB) and the Ethical Committee for Animal Welfare (reference
no. 260N).
Animal treatments
The pan-caspase inhibitor Z-VAD-FKM was injected intraperi-
toneally daily at 10 mg/g body weight to pregnant females from
E10 to E17.
To perform proliferation studies, BrdU (Sigma-Aldrich) was
injected intraperitoneally at 50 mg/kg twice daily for 24 h for
the proliferation analyses and from P3 to P5 for the label
retention studies. Doxycycline was administered to pregnant
and lactating female K5tTA;TetO-H2B-GFP and K5tTA;TetO-
H2B-GFP;K14Cre;Brca1fl/fl mice in food pellets, starting at
E18.5.
K5CreER;Brca1fl/fl;Rosa-YFP mice were injected intraperito-
neally with 2.5 mg of TAM every other day until a total dose of
15 mg.
Antibodies
For immunofluorescence, the following antibodies were used:
anti-P-Cadherin (rat, 1:200; Zymed); anti-GFP (rabbit, 1:1000;
Abcam); anti-b4 integrin (rat, 1:200; BD Biosciences); anti-K14
(chicken, 1:10,000; Covance); anti-K10 (rabbit, 1:1000; Covance);
anti-K1 (rabbit, 1:1000; Covance); anti-Loricrin (rabbit, 1:1000;
Covance); anti-Lrig1 (goat, 1:1000; R&D Systems); anti-Gata3
(mouse, 1:100; Santa Cruz Biotechnology); anti-Lhx2 (1:500;
Santa Cruz Biotechnology); anti-Dsc2 (1:50; Santa Cruz Bio-
technology); anti-BrdU (rat, 1:400; Abcam); anti-active caspase-3
(rabbit, 1:600; R&D Systems); anti-CD34 (rat, 1:100; eBioscien-
ces); anti-gH2AX (mouse, 1:600; Millipore); anti-53BP1 (rabbit,
1:500; Novus Biological); anti-AE13, anti-AE15, and anti-Nfatc1
(all 1:100; Abcam); anti-b-catenin (1:500; Abcam); anti-rat, anti-
mouse, anti-goat, anti-chicken, and anti-rabbit conjugated with
Alexa-488 (all donkey, 1:400; Invitrogen); and anti-rat and rabbit
conjugated with RRX (donkey, 1:400; Jackson Immunoresearch).
Anti-MTS24 (1:200) was a kind gift from Richard Boyd (Monash
Immunology and Stem Cell). Rabbit antiserum to NPNT was
generated as described previously (Sato et al. 2009).
The mouse monoclonal anti-mouse BRCA1 antibody (mBRCA1-
16588) was raised against a C-terminal fragment of the mouse
BRCA1 protein. A construct encoding residues 1328–1821 was
kindly provided by Stoil Dimitrov and David Livingston (Dana
Farber Cancer Institute, Harvard Medical School, Boston) and
recloned into the GST-LIC vector pGEXNKI-GST-3C-LIC (Luna-
Vargas et al. 2011) to allow recombinant protein purification.
Purified protein was used to generate mouse hybridoma cell lines
(BioGenes).
For FACS analysis, the following antibodies were used: bio-
tinylated anti-CD34 (1:50; EBiosciences), PE-conjugated anti-a6
integrin (1:50), FITC-conjugated anti-BrdU (1:50), and APC-
conjugated streptavidin (1:400; all by BD Biosciences).
For Western blot, we used the following antibodies: anti-
gH2AX (1:1000; Millipore) and anti-actin (1:1000; Abcam).
Immunofluorescence
Paraffin sections were performed and stained as previously
described (Sotiropoulou et al. 2010). Antigen unmasking was
performed in the PT module (LabVision) for 20 min at 98°C using
citrate buffer (pH 6.0; LabVision).
Frozen sections from cryopreserved tissue, embedded in
cryomold (Sakura) using OCT (Tissue Tek), were performed on
Superfrost slides (Menzel GmbH) using a cryostat CM-3050-S
(Leica) and were fixed for 10 min in paraformaldehyde 4% in PBS.
Nonspecific antibody binding was prevented by blocking with
5% horse serum (HS), 1% BSA, and 0.2% Triton X-100 for 1 h at
room temperature. When mouse primary antibodies were used,
nonspecific antigen blocking was performed using the M.O.M.
Basic kit reagent (Vector Laboratories) according to the manu-
facturer’s instructions. Slides were then incubated overnight
at 4°C in the presence of the primary antibodies, followed by 1 h
of incubation of the secondary antibodies at room temperature.
Slides were mounted using Glycergel (Dako) supplemented with
2.5% DABCO (Sigma-Aldrich).
For gH2AX immunofluorescence, the following modifications
from the above protocol were made: The cryosections were fixed
for 20 min in 2% paraformaldehyde in PBS and, upon washing,
were incubated in 70% ethanol for 20 min at20°C. Nonspecific
antibody binding was prevented by blocking with 8% BSA, 0.5%
Tween 20, and 0.1% Triton X-100 for 1 h at room temperature.
Immunohistochemistry
For p53, 4-mm paraffin sections were deparaffinized and rehy-
drated. For Brca1, cryosections were used. The antigen unmask-
ing procedure was performed for 20 min at 98°C in citrate buffer
(pH 6) using the PT module. Endogenous peroxydase was blocked
using 3% H2O2 (Merck) in methanol (VWR) for 10 min at room
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temperature. Endogenous avidin and biotin were blocked using
the Endogenous Blocking kit (Invitrogen) for 20 min at room
temperature. In p53 staining, nonspecific antigen blocking was
performed using M.O.M. Basic kit reagent. Mouse anti-p53
antibody (clone 1C12; Cell Signaling) was incubated overnight
at 4°C. Anti-mouse biotinylated in M.O.M. Blocking kit, Stan-
dard ABC kit, and ImmPACT DAB (Vector Laboratories) was
used for the detection of HRP activity. Slides were then dehy-
drated and mounted using SafeMount (Labonord).
Oil Red O staining
Oil Red O staining was performed by 30 sec of incubation in Oil
Red O of cryosections previously fixed with 4% PAF for 10 min
and permeabilized with 60% isopropanol for 5 min. Slides were
thoroughly washed with tap water, stained with Mayer’s hema-
toxylin for 2 min, washed with water, and mounted.
Image acquisition
Imaging was performed on a Zeiss Axio Imager.M1 (Thornwood)
fluorescence microscope with a Zeiss Axiocam MRm camera for
immunofluorescence microscopy and a Zeiss Axioxam MRC5
camera for bright-field microscopy using Axiovision release 4.6
software. Confocal images were acquired at room temperature
using a Zeiss LSM780 multiphoton confocal microscope fitted
on an Axiovert M200 inverted microscope equipped with
C-Apochromat (403, NA 1.2) water immersion objectives (Carl
Zeiss, Inc.). Optical sections of 1024 3 1024 pixels were collected
sequentially for each fluorochrome. The data sets generated were
merged and displayed with the ZEN software. Photoshop CS3
(Adobe) was used to adjust brightness, contrast, and picture size.
Flow cytometry and cell sorting
For flow cytometry, isolation of keratinocytes and bulge SCs was
performed as previously described (Sotiropoulou et al. 2010).
FACS analysis for cell proliferation was performed using the
BrdU Flow kit (BD Biosciences). Dead cells were excluded using
Hoechst 33342 at 4 mM. FACS analysis was performed using LSR
Fortessa and FACS DiVa software (BD Biosciences). For cell
sorting, IFE and HF cells were isolated as previously described
(Lichti et al. 2008). The FACSAria cell sorter (BD Biosciences)
and FACS DiVa software were used for cell sorting.
Western blot analysis
FACS-sorted cells (105) were lysed in 50 mL of laemli lysis buffer
for 10 min at 100°C and sonicated at 30% amplitude seven times
for 2 sec each. Subsequently, 30 mL of lysate was loaded on a 10%
acrylamide/bis-acrylamide gel (Invitrogen). Proteins were then
transferred on PVDF membranes. ECL anti-mouse IgG conju-
gated with horseradish peroxidase (1:10,000; Healthcare) was
used as the secondary antibody.
Quantitative PCR
DNA purification from FACS-sorted cells was performed using
the DNeasy blood and tissue kit (Qiagen). quantitative PCR
analyses were performed using a Quantifast SYBR Green mix
(Qiagen) on an Agilent Technologies Stratagene Mx3500P real-
time PCR system. b-Actin was used as the housekeeping in-
ternal reference gene. The primers and conditions used were
previously described (Liu et al. 2007). Specificity of the PCR
amplification was assessed by electrophoresis of the amplicons
on 2% agarose gels.
Statistical analysis
Statistical significance was computed using Student’s t-test
statistics.
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